| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 7, 2023 | Jun 8, 2023 | Theriva Biologics, Inc. | CEO | Buy | 85.0 | +14,000 | 5.93% | ✗ | $9.7K |
| Jun 6, 2023 | Jun 7, 2023 | Theriva Biologics, Inc. | CEO | Buy | 91.3 | +26,000 | 12.38% | ✗ | $16.5K |
| Feb 10, 2023 | Feb 13, 2023 | Theriva Biologics, Inc. | CEO | Buy | 91.3 | +25,000 | 13.51% | ✗ | $26.1K |
| Feb 2, 2023 | Feb 3, 2023 | Theriva Biologics, Inc. | CEO | Buy | 91.3 | +25,000 | 15.63% | ✗ | $23.5K |
| Jan 25, 2023 | Jan 26, 2023 | Theriva Biologics, Inc. | CEO | Buy | 91.3 | +25,000 | 18.52% | ✗ | $21.8K |
| Jan 20, 2023 | Jan 23, 2023 | Theriva Biologics, Inc. | CEO | Buy | 91.3 | +25,000 | 22.73% | ✗ | $18.7K |
| Dec 29, 2022 | Jan 3, 2023 | Theriva Biologics, Inc. | CEO | Buy | 91.3 | +100,000 | 1000.00% | ✗ | $43.7K |
| May 10, 2021 | May 10, 2021 | Theriva Biologics, Inc. | CEO | Buy | 91.3 | +50,000 | 100.00% | ✗ | $24.6K |
| Aug 23, 2019 | Aug 26, 2019 | Theriva Biologics, Inc. | CEO | Buy | 91.3 | +50,000 | 100.00% | ✗ | $20.8K |
| Aug 26, 2014 | Aug 27, 2014 | Nuo Therapeutics, Inc. | CFO | Buy | 91.3 | +27,500 | 52.88% | ✗ | $10.5K |
| Aug 20, 2014 | Aug 21, 2014 | Nuo Therapeutics, Inc. | CFO | Buy | 91.3 | +52,000 | 100.00% | ✗ | $20.3K |